Kalkine
Business Services · Australia · 201-500 Employees
View Company Info for Free
Overview
Headquarters
234 George St Ste 202, Sydney, New South...Phone Number
+61 286673147Website
www.kalkine.com.auRevenue
$6.6 MillionIndustry
About Kalkine
Kalkine Org Chart
Is Kalkine your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Check out if Kalkine is spiking on competitors!
Click to see if Kalkine had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Kalkine
Product Launch: Get notified when Kalkine launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Kalkine recently announced quarterly report
Kalkine, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Kalkine has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Kalkine has new funding data
Recommended Actions
Reach out to Masked Content who joined Kalkine as Masked Content
Find 2 more new buyers
Compare Similar Companies to Kalkine
Compare insights from companies similar to Kalkine, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Kalkine is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Kalkine is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Kalkine.
Kalkine Tech Stack
A closer look at the technologies used by Kalkine
Kalkine News & Media
Neurotech International Secures $3.15 Million R&D Tax Incentive Loan to Advance Clinical Studies
Neurotech International Limited has announced a significant financial boost through a $3.15 million secured loan agreement with Rockford RDF Pty Ltd. The funds are earmarked for supporting the company's Phase III clinical studies in Autism Spectrum Disorder (ASD) and other research initiatives. This development is pivotal for investors as it provides non-dilutive funding, enhancing the company's financial stability without affecting shareholder equity.Citigold (ASX:CTO): Queensland Gold Ambitions Return to the Investor Spotlight - Kalkine
Citigold (ASX:CTO): Queensland Gold Ambitions Return to the Investor SpotlightAmpol (ASX:ALD) Secures $400 Million Funding Facility as Oil-Market Volatility Intensifies
Ampol (ASX:ALD) Secures $400 Million Funding Facility as Oil-Market Volatility IntensifiesComet Ridge Limited Appoints Mark Nicholas McCabe to Board of Directors - Kalkine
Comet Ridge Limited has formally notified the market of the appointment of Mark Nicholas McCabe as a new director, with an official start date of 13 July 2026. The company lodged an Initial Director's Interest Notice in accordance with ASX Listing Rule 3.19A.1 and section 205G of the Corporations Act, disclosing Mr McCabe's relevant interests in securities and contracts at the time of appointment. The notice confirms that Mr McCabe holds no direct or indirect
Top Business Services Companies
Top companies in Canada by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Kalkine
Kalkine offers comprehensive stock market insights and analysis, catering to both novice and seasoned investors. Their services include a wide range of research reports, expert recommendations, and market updates across various asset classes, ensuring clients stay informed and make strategic investment decisions. With over 30 premium data points an... Read More